On July 7th, OBIO held a Roundtable Discussion with health science companies on Governance. The Roundtable covered two practical aspects of governance - building and managing a BoD. This blog summarizes the key, take-home nuggets from the event.

Last week, OBIO organized and hosted a virtual roundtable discussion with health science companies that participated in the Ontario delegation to the BIO Digital 2020 conference. The interactive discussion allowed participants to share their experiences about adjusting to building companies virtually.

Last week OBIO hosted our newest H2BB trainees for the introductory sessions of our Innovation & Commercialization and Project Management training modules.

The 2020 Niagara Investment Summit brought together a record number of health science industry leaders, entrepreneurs and global investors to meet, learn and be inspired. Summaries and photo galleries are now available.

On November 4th, OBIO hosted Amplify Capital (formerly MaRS Catalyst Fund) and heard from Kathryn Worstman (Managing Partner, Amplify Capital) and Gonen Hollander (Senior Associate, Amplify Capital) present their impact investment strategy.

On September 17th, OBIO held a dinner to bring together CAAP and CAAP Alumni companies. OBIO would like to thank everyone who came out and joined us to discuss common experiences, challenges and what's coming next.

On September 10th, OBIO organized a cross-border networking event in Boston at the Consulate General of Canada. The event was supported by the Consulate General and law firms Fasken and Choate. Over 45 investors, strategics, as well as executives from high potential Canadian health science companies packed the Canada Room at the Consulate and resulted in numerous investor-company interactions.

On August 21st, OBIO hosted Norton Rose Fulbright’s Anthony de Fazekas (Partner, Head of Technology & Innovation) and Vanessa Grant (Partner), Lumira Ventures’ Jacki Jenuth (Partner), and University of Toronto’s Karen Temple (Commercialization Manager) who discussed practical considerations for licensing health science technologies from tech transfer offices, and how these agreements can impact a company’s future investability.

On July 25th, OBIO hosted a Happy Hour Networking event attended by over 40 CEOs and senior health science company executives. Attendees networked with fellow entrepreneurs and heard about OBIO’s upcoming plans for the fall.

On July 11th, OBIO presented the “Optimize your next round of funding” workshop for CAAP & Health MINT companies. The workshop was led by Nick Kuryluk of Virtus Insights.

On June 25th, OBIO hosted 'Is the Price Right? Pricing Your Innovative Healthcare Product' which featured a presentation by Amy Siegel (C-Founder, S2N Health).

On June 10th, OBIO hosted a Pitches & Pitchers event, supported by Lumira Ventures and Whitecap Venture Partners.